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1. Introduction  
Many advances in reproductive medicine in the past five decades have made 
cryopreservation of human spermatozoa an invaluable tool for the clinical management of 
infertility and sperm banking. The advent of in vitro fertilization (IVF) and intracytoplasmic 
sperm injection (ICSI) with microsurgical sperm handling techniques along with advances 
in female gamete acquisition have resulted in an increased demand for the cryopreservation 
of semen and tissue samples, often containing a very limited number of spermatozoa. Sperm 
cryopreservation also makes it possible for cancer patients to preserve their fertility prior to 
gonadotoxic chemotherapy or radiation. Applications of sperm banking are not limited to 
cancer patients but extend to patients undergoing certain types of pelvic or testicular 
surgeries; those who suffer from degenerative illnesses such as diabetes or multiple 
sclerosis; spinal cord disease or injury; and persons in occupations where a significant risk 
of gonadotoxicity prevails. Sperm cryopreservation is also available to men undergoing 
surgical sterilization such as vasectomy, in the event that children may be desired in the 
future. Another use for semen cryopreservation is to allow donor semen samples to be 
quarantined while appropriate screening is performed to prevent the transmission of 
infectious pathogens during therapeutic donor insemination (TDI).  
Although major improvements have been made in sperm cryopreservation, there are many 
unresolved technical issues. Since freezing protocols differ between types of cells, the ideal 
conditions for human sperm freezing and thawing need to be perfected. To add more 
complexity, samples with abnormal semen parameters, such as severe oligospermia or high 
seminal fluid viscosity, often require unique cryopreservation conditions. For example, the 
particular cryoprotectants can affect cooling rates. In addition, storage temperature can 
significantly influence cryopreservation outcome. Liquid nitrogen (LN2) can offer long-term 
survival of spermatozoa due to essentially absent metabolic activity, such as chemical 
reactions, genetic modification or aging of cells (Mazur, 1984). A conventional slow freezing 
protocol has been in use for many years and very little has changed in terms of 
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methodology and reagents. While freezing aims to preserve cells it can also easily destroy 
them if certain precautionary steps are not taken into consideration. During 
cryopreservation cells and tissue undergo dramatic transformation in chemical and physical 
characteristics as the temperature drops from +37 to -196°C. The cells can lose up to 95% of 
their intracellular water. The concentration of solutes increases considerably, triggering the 
possibility of osmotic shock. Moreover, potential intracellular ice crystallization and 
mechanical deformation by extracellular ice may cause significant injury leading to cell 
death. Furthermore, if cells survive freezing, they might sustain additional damage during 
the thawing process due to osmotic shock, uncontrollable swelling and ice re-crystallization 
(Woods, et al., 2004). 
Recently scientists have begun to re-investigate the utility of ultra rapid freezing in the 
search for alternative methods of sperm cryopreservation. Slow freezing of sperm utilizes 
cooling rates of 1–10°C/min, while the rapid freezing, or vitrification, technique allows for 
cooling rates to reach more than 40-1000°C/min in order to avoid intracellular ice formation. 
As new techniques are perfected, there is a potential for sperm cryopreservation to greatly 
improve in the future.  
2. Cryopreservation of human spermatozoa 
2.1 History of human spermatozoa cryopreservation  
Remarkably, the first reference of empirical sperm freezing dates as far back as the late 16th 
century, but it was only with the discovery in 1937 by Bernstein and Petropavlovski that 
glycerol can aid spermatozoa in surviving long term freezing, that sperm cryopreservation 
became practical. Expansion of artificial insemination for the dairy industry led to further 
important research in the field of cryobiology (E. Isachenko, 2003, as sited in Bernstein & 
Petropavlovski, Polge et al., 1949). Shortly after these practices were initiated with animals, 
the first pregnancies were reported in humans after insemination with frozen spermatozoa. 
The next milestone was the discovery of the possibility to store human spermatozoa in LN2 
at -196°C, resulting in superior recovery rates compared to storage at higher temperatures 
between -20 and -75°C. After the era of empirical freezing; cryobiology matured to its 
fundamental stage, focusing on the biophysical and biochemical principals of 
cryopreservation, further advancing the field (Mazur et al., 1972. A comprehensive review 
of the historical background of sperm freezing was recently published and is recommended 
for readers looking for more details (Katkov et al., 2006).  
2.2 Biological aspects of freezing 
Living cells have an isotonic condition with a melting point of their intracellular water of 
approximately -0.6°C. When cells are cooled below this standard freezing point, 
supercooling takes place and remains in a metastable state up to -5°C (Katkov et al., 2006; 
Mazur et al., 1972). Water crystallization and ice formation begin between -5 and -15°C, 
beginning with the formation of an ice nucleus (seed crystal) in the extracellular water. This 
‘nucleation’ can be induced at a higher temperature by the planned external facilitation of 
ice formation, often referred to as “seeding”. Prior to that stage, water remains unfrozen 
inside the cell as the membrane prevents ice crystals from intracellular penetration (Woods 
et al., 2004). Solutes are excluded from ice formation which results in rising concentrations 
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of solutes within extracellular water. Due to the permeability of the plasma membrane, this 
chemical imbalance sets up the diffusion of solutes into the cell, forcing water out of the cell. 
Cells thus undergo excessive dehydration, losing up to 95% of their intracellular water 
content. This increases the intracellular concentration of solutes, resulting in denaturation of 
proteins, pH shifts and potential cell death. 
Since velocity of cooling is crucial, inaccurate cooling rates can negatively affect sperm 
survival, motility, plasma membrane integrity and mitochondrial function (Henry et al., 
1993). When cooling is slow enough, there is sufficient time for intracellular water efflux and 
balanced dehydration. If cooling is too slow, damage may occur due to exposure of cells to 
high concentrations of intracellular solutes. Extreme cellular dehydration leads to shrinkage 
of cells below the minimum cell volume necessary to maintain its cytoskeleton, genome-
related structures, and ultimately cellular viability (Mazur, 1984). On the other hand, if 
cooling rates are too fast, external ice can induce intracellular ice formation and potential 
rupture of the plasma membrane and damage intracellular organelles. In addition, 
mechanical damage of cells is possible due to of extracellular ice compression and close 
proximity of frozen cells can result in cellular deformation and membrane damage 
(Fujikawa & Miura, 1986). In contrast, with ultra rapid cooling, the amount of ice formation 
is insignificant and the entire cell suspension undergoes vitrification. At this stage water 
transitions, ice formation slows, molecular diffusion and aging stops, and liquids turn into a 
glass-like condition (Katkov et al., 2006). 
Despite the relative insensitivity of human sperm to freezing, optimal cooling rates are 
needed to ensure appropriate sperm recovery. Currently, there are two types of slow 
freezing, either static vapour phase freezing to a certain temperature, or the multistep 
approach using nonlinear controlled-rate freezers, followed by plunging into LN2. Most 
laboratories and sperm banks adapt simple static vapour phase cooling in order to avoid 
induction of ice nucleation by seeding. For this technique samples are lowered into a vapour 
phase just above the LN2 level, allowing them to cool for 15-20 minutes before being 
plunged into LN2. Alternately, controlled rate freezers can be used to cryopreserve human 
semen. Most of these protocols utilize  a “no seeding” option where samples are cooled from 
room temperature to -4°C at the rate of 2°C/min, followed by an increase of the cooling rate 
to 10°C/min until -100°C is reached, and finally plunging into LN2 (Morris et al., 1999). In 
contrast to these slow freezing techniques, single step ultra rapid cooling is used for the 
vitrification technique. 
2.3 Cryoprotective agents (CPAs)  
Most cells would not survive cryopreservation without CPAs, which can minimize cryo-
injury of cells. CPAs are low molecular weight chemicals that serve to protect spermatozoa 
from freezing damage or ice crystallization by decreasing the freezing point of materials. 
There are two categories of CPAs, and they differ in their ability to penetrate the plasma 
membrane. Firstly, permeating CPAs such as dimethylacetaldehyde; dimethyl sulfoxide, 
glycerol, glycol, ethylene and methanol, stabilize cell plasma membrane proteins and reduce 
concentrations of electrolytes (Arakawa et al., 1990). In contrast, nonpermeating CPAs such 
as albumins, dextrans, egg yolk citrate, hydroxyethyl, polyethylene glycols, polyvinyl 
pyrollidone and sucrose, minimize intracellular crystallization by increasing viscosity of the 
sample. CPAs themselves can be toxic if used at high concentrations and spermatozoa are 
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vulnerable to osmotic changes induced by these agents (Gao et al., 1993). Despite the use of 
CPAs, plasma membranes can still be damaged or ruptured due to the initial extensive 
dehydration followed by cell swelling and osmotic stress. Gradual introduction of CPAs to 
the cell suspension or stepwise increase in their concentration, with a limited waiting period 
prior to freezing, is utilized to minimize the potential negative effects of these agents 
(McGann & Farrant, 1976).  
2.4 Biological aspects of thawing 
While there are many risk factors associated with freezing of cells, thawing can also 
dramatically affect survival rates of spermatozoa. When frozen samples are returned to 
ambient temperature, a reversal of the freezing process takes place. Cells that were frozen 
by the slow method, are more vulnerable to rapid thawing, due to the fast influx of water 
into cells causing uncontrollable swelling and osmotic shock (Curry & Watson, 1994). If cells 
were frozen rapidly, intracellular ice crystals could re-crystallize and form larger crystals 
during a slow thaw. To minimize toxic effects, CPAs have to be promptly removed from the 
cell suspension by washing samples in isotonic solution. Therefore, the thawing process and 
CPAs removal technique utilized must take into account the original method that was used 
for freezing. 
2.5 Cryopreservation of spermatozoa for assisted reproductive techniques (ART) 
Sperm cryopreservation is widely used in combination with ART techniques such as 
intrauterine insemination (IUI), IVF and ICSI. Despite many years of research and the 
discovery of new CPAs, significant numbers of spermatozoa still do not survive 
cryopreservation (Morris, 1999). Both freezing and thawing can inflict irreversible injury on 
a proportion of human spermatozoa, marked by a significant increase in some apoptosis 
markers (Giraud et al., 2000). Lipid peroxidation can lead to a decrease in sperm velocity, 
motility, viability, and mitochondrial activity (Mossad et al. 1994; O’Connell et al. 2002). The 
recovery rates of intact spermatozoa are highly dependant on the pre-freezing sample 
quality (de Paula et al., 2006). Poor quality semen may be more prone to DNA damage and 
cell death after cryopreservation than normal semen samples and thus have lower fertilizing 
capacity (Borges et al., 2007). It has been shown that reactive oxygen species (ROS) 
production impacts membrane fluidity and the recovery of motile, viable spermatozoa after 
cryopreservation. As well, semen samples containing leukocytes may have higher DNA 
fragmentation. In addition, the cryopreservation process can diminish the antioxidant 
activity of the semen fluid making spermatozoa more susceptible to ROS-induced damage 
(Lasso et al., 1994). The occurrence of sperm DNA damage may also be associated with the 
thawing process. A rapid increase in post thaw sperm DNA fragmentation over time has 
been observed, with the highest rate of fragmentation occurring during the first four hours 
after thawing (Gosalvez et al., 2009).  
Normozoospermic semen samples appear to be more resistant to damage induced by 
freezing and thawing compared with oligozoospermic or asthenozoospermic samples. It has 
been reported that motile spermatozoa can be recovered after five refreezing and thawing 
rounds in normozoospermic samples, but only after two rounds in cases of oligozoospermia 
(Verza et al., 2009). Spermatozoa of infertile men were also found to be less resistant to 
damage during cryopreservation compared with spermatozoa from fertile men (Donnelly et 
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al., 2001). Optimization of both CPAs concentrations and cryopreservation protocols will 
maximize survival of spermatozoa and thus improve ART outcome. 
2.6 Cryopreservation of epididymal and testicular spermatozoa  
Couples with male factor infertility represent 30 to 40% of the infertile population. 
Azoospermia accounts for 10% of cases of confirmed male infertility, and often requires 
surgical retrieval of spermatozoa. Since the introduction of ICSI, many cases of severe male 
infertility can now be successfully treated. Cryopreservation of surgically retrieved 
spermatozoa is a valuable component in the effective management of male infertility, reducing 
the necessity of repeat surgeries. Diagnostic sperm retrieval prior to IVF has several benefits 
including the possibility of freezing spermatozoa for future use, or if none are retrieved, 
initiation of the IVF stimulation cycle can be postponed or avoided. Testicular spermatozoa 
have been utilized to achieve pregnancy in couples with severe male factor infertility, with 
reported pregnancy rates similar to ejaculated spermatozoa, according to a meta-analysis 
study (Nicopoullos et al., 2004). In the case of obstructive azoospermia, recovery of 
spermatozoa by aspirations varies from 45 to 97% (Craft et al., 1995; Lania et al., 2006). In cases 
of non obstructive azoospermia recovery depends on the degree of testicular pathology and 
varies from 0 to 64% (Schlegel et al., 1997; Hauser et al., 2006). A second or third surgery can 
increase the chance of complications including hematomas, inflammation, testicular 
devascularization, fibrosis and permanent testicular damage (Schlegel and Su, 1997). To avoid 
this, if pregnancy is not achieved during the first ICSI attempt, a repeat of the surgical 
procedure would not be required if a portion of the surgical specimen has been banked. 
Cryopreservation of surgically retrieved spermatozoa can also aid the coordination of oocyte 
retrieval and avoids the pressure of having the urologist available on the day of the ICSI 
procedure. Usually the number of spermatozoa obtained during a surgical procedure is 
limited, and in the case of testicular sperm they may not be fully matured. In the future, if no 
mature spermatozoa are recovered, spermatogonial stem cells or early germs cells could 
potentially be matured in vitro and used for fertility treatments (Hwang & Lamb, 2010).  
There are significant technical challenges for successful cryopreservation of testicular tissue 
due to its complex structure and intracellular interactions. Different cells of testicular tissue 
will have dissimilar responses to cryopreservation and require different concentration of 
CPAs. Freezing larger pieces of tissue is not advisable as it would increase resistance of heat 
transfer and penetration of CPAs leading to variation in cooling rates within different parts 
of the tissue. In addition, seminiferous tubules capture liquid and increase chances of ice 
formation (Woods et al., 2004). To avoid these difficulties, cryopreservation of smaller tissue 
fragments or mincing tissue prior to freezing has been advocated (Hovatta, 2003). 
2.7 Cryopreservation of low number or single spermatozoa  
The idea of cryopreservation of low numbers or individual spermatozoa was introduced more 
than a decade ago (Cohen et al., 1997). While this approach remains very attractive, there are 
multiple biological and technical issues to overcome. Early attempts to freeze individual 
spermatozoa were performed by placing them in empty animal or human zona pellucida 
prefilled with CPAs (Walmsley et al., 1998). Data from these studies suggested lower recovery 
and fertilization rates with human zona in comparison to hamster, possibly due to the 
presence of the ZP3 binding protein and induced acrosome reactions when human zona were 
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used (Cohen et al., 1997). While this method requires special skills, equipment, and is very 
labour-intensive; live births were reported using both human and hamster zona (Walmsley et 
al., 1998). Spermatozoa were also injected and frozen within spheres of Volvox Globator algae 
and recovered after thawing using an ICSI needle (Just et al., 2004). While all of these methods 
appear to be attractive for single spermatozoa cryopreservation, they have a number of 
limitations. Issues around the use of donor human zona pellucida as well as exposure of 
human gametes to animal or algae genetic materials present potential risks that restrict the use 
of such methods for human ART procedures. While in theory zona could be obtained from the 
female partner of men with severe male infertility, this would be unrealistic in the clinical 
setting, as it would require IVF egg retrieval and destruction of ooplasma to obtain empty 
zona pellucidae. An alternative proposal would be to use a non-biological carrier such as non-
toxic polysaccharide alginate agarose to cryopreserve small numbers of sperm (Herrler et al., 
2006, Isaev et al., 2007). In these studies spermatozoa were mixed with CPAs and added to the 
alginate before the gelatin stage and then frozen in small bead microspheres. After 
cryopreservation, they were dissolved in a sodium citrate solution. The residual alginic acid on 
the sperm membrane can reduce sperm motility with slow freezing (Herrler et al., 2006). 
Agarose microspheres were also frozen in 0.25 cc straws by vitrification with better recovery 
rates (Isaev et al., 2007). Another reported method was to divide the sample into several small 
aliquots of 15–20-µl and to freeze in 0.2-mm cryopreservation embryo straws cut into smaller 
sections, sealed on one end (Desai et al., 2004).Conventional and open-pulled straws 
containing 1 or 5 µl of sperm suspension frozen by vitrification has also been reported (V. 
Isachenko et al., 2005). However, individual spermatozoa could not be easily sequestered 
because of possible adherence to the walls of the straws. ICSI pipettes were suggested as a 
container to freeze individual spermatozoa by either the slow method or vitrification 
(AbdelHafez et al., 2009; Sohn et al., 2003). Cryopreservation of sperm in microdroplets 
containing 1 or 40 μl of spermatozoa in cryoprotectant placed on a cold surface or directly 
plunged into liquid nitrogen was also reported (Gil-Salom et al., 2000; Isachenko et al., 2005). 
Microdroplets covered by mineral oil in a plastic tissue culture dish placed in liquid nitrogen 
were also used to cryopreserve individual spermatozoa (Quintans et al., 2000; Sereni et al., 
2008). A nylon cryoloop first introduced for embryo freezing was successfully used to 
cryopreserve small volumes of sperm suspension by both slow freezing and vitrification 
(Nawroth et al., 2002; Schuster et al., 2003; V. Isachenko et al., 2004; Desai et al., 2004). 
However direct placement of sperm into LN2 without a container using an ‘open system’ such 
as cryoloop or unsealed culture dish increases the risk of cross-contamination and such 
techniques are discouraged by regulatory agencies such as the FDA and the European Tissue 
Directive on Sperm.  
Overall reported recovery rates of a known number of frozen spermatozoa varied from 59 to 
100% with reported survival rates of 8–85% and motility of 0 to 100%. The wide ranges of 
results depended on patient population, initial quality and number of frozen spermatozoa, 
as well as the type of cryopreservation device, type of cryoprotectant, and freezing and 
thawing protocols. 
2.8 Sperm packaging and relation to the method of cryopreservation 
Storage of frozen samples has to be in suitable freezing containers and at an optimal 
temperature to ensure long term survival. The packaging containers must meet several 
criteria. They must: 1)hold freezing temperatures without cracking or leaking, 2)have a large 
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surface to enable a uniform cooling rate of the sample, 3)have proper heat exchange 
properties, 4)be easy to label and seal securely and 5)be available in small sterile units. 
When storage packaging is chosen, the possible risk of microbial or viral contamination 
must also be considered. The type of packaging also depends on the freezing protocol and 
sometimes on the quality of the sample. For conventional slow freezing, the two most 
common types of containers currently used are plastic screw-top vials or straws. Straws can 
be made of polyethylene terephthalate glycol (PETG) or ionomeric resin (CBS High Security 
Straws by CryoBioSystem, Paris, France). As described above, a low number or single 
spermatozoa have been experimentally frozen in empty animal or human zona pellucida, 
spheres of Volvox Globator algae, alginate agarose bead microspheres and ICSI pipettes 
(AbdelHafez et al., 2009; Herrler et al., 2006; Isaev et al., 2007; Just et al., 2004; Walmsley et 
al., 1998). For vitrification purposes different types of storing strategies have been 
suggested. These include: cryoloops, electron microscope copper grids, nylon meshes, open-
pulled straws and standard open straws (V. Isachenko et al., 2005). 
3. Cryopreservation of human spermatozoa by vitrification 
3.1 Background on vitrification of spermatozoa  
Vitrification is an alternative method of freezing based on the rapid coolling of water to a 
glassy state through extreme elevation of viscosity without intracellular ice crystallization 
(Fahy, 1986; Katkov et al., 2006). The relationship between the size of different cells, 
particularly, different spermatozoa species, and the ability of cells to be vitrified are 
discussed in details in the paper by Katkov (Katkov et al., 2006).  
The earliest experiments on vitrification from the 1930s was not successful because critical 
rates of cooling were unachievable at that time. With the use of LN2 and the discovery of 
cryoprotectants, however, it became possible to vitrify many types of cells. The five basic 
ways to achieve vitrification have been described in details by Katkov et al.: equilibrium 
freezing-out of the bulk of water with the use of CPAs and storage at ultra low temperature; 
lyophilization using slow freezing to moderately low (-40 °C) followed by secondary drying 
at +30°C (mostly used in food and pharmaceutical industries); ice-free vitrification at high 
rates and high concentration of CPAs; ice-free vitrification at very fast rates without 
permeable agents (“CPAs-free vitrification”); high temperature’ vitrification by  air/vacuum 
drying at temperature above 0°C (Katkov et al., 2006).  
However, until only recently, vitrification of spermatozoa was unsuccessful, possibly due to 
high concentrations of permeable CPAs (30-50% compared to 5-7% with slow freezing) and 
low tolerance of spermatozoa to permeable agents. Even brief exposure to a high 
concentration of CPAs can lead to toxic and osmotic shock and would be lethal for 
spermatozoa. One possible strategy to lower the concentration of CPAs could be to increase 
the speed of cooling and warming temperatures as higher rates of cooling and warming, 
require lower concentrations of CPAs; these conditions can help eliminate intracellular ice 
crystallization, and facilitate the formation of a glassy state (Katkov et al., 2006). Another 
option is to add non-permeable CPAs--such as carbohydrates--to permeable CPAs to 
minimize osmotic shock by decreasing osmotic pressure and stabilizing the nuclear 
membrane. Since the intracellular matrix of human spermatozoa contains large amounts of 
proteins and sugars, they can be successfully frozen in the absence of permeable CPAs using 
protein- and sugar-rich non-permeable agents (Koshimoto et al., 2000).  
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Successful vitrification of human spermatozoa was first reported by the Isaschenkos’ group 
(Nawroth et al, 2002; E. Isachenko et al, 2003). The high viscosity of the intracellular milieu 
due to large amounts of proteins, nucleotides and sugars and low water in human 
spermatozoa content determines the ability of human sperm to be vitrified at relatively 
low cooling rates (Katkov et al., 2006). It was noted that human spermatozoon is one of 
the smallest germ cells among mammals, has almost no residual histones and has very 
compacted DNA (Holt, 2000), which indirectly confirms this hypothesis (see also Chapter 
by Katkov et al in this Book). 
As we mentioned above, the major breakthrough in successful vitrification of human 
spermatozoa without the use of permeable CPAs was reported only recently by the 
Isachenko group (Nawroth et al., 2002), who actually re-invented the work of the “pioneers” 
in the 1930-40s mentioned above. The combination of extremely high rates of 
cooling/warming and utilization of vitrification media containing proteins and 
polysaccharides made it feasible to avoid de-vitrification during warming without use of 
toxic CPAs. The same group compared viability, survival rate and sperm DNA damage 
between slow freezing and vitrification and found that DNA integrity was independent 
from the mode of cooling and the presence of cryoprotectants in thawed spermatozoa (V. 
Isachenko et al., 2004). The acrosome reaction, capacitiation and mitochondrial activity of 
spermatozoa were compared vis-a-vis slow freezing and vitrification (E. Isachenko et al., 
2008). The group reported that changes in the mitochondrial membrane potentials relate to 
the type of vitrification media with the best achieved results when both sugar and albumin 
were added to the media. To achieve high cooling rates the vitrification specimen volume 
needs to be kept to a minimum. Specially designed freezing carriers such as cryoloops and 
electron microscope copper grids have been suggested for vitrification of human 
spermatozoa (E. Isachenko et al., 2003; Nawroth et al., 2002). However, placing drops of 
semen directly into LN2 raises the issue of the potential risk of microbial or viral cross 
contamination during freezing and storage (Katkov, 2002). The development of aseptic 
techniques of vitrification allowing to freeze 5-10 µl of sperm suspension in open-pulled 
straws (OPS) or 1-2 µl of sample cut standard straw (CSS) placed inside of insemination 
straw further advanced the methodology of human sperm vitrification (V. Isachenko et al., 
2005). The ultra-high freezing rates utilized for vitrification, via direct plunging of 
specimens into LN2, leads to solidification of a solution by an intense increase in viscosity 
during cooling which avoids water crystallization and damaging ice formation (Katkov et 
al., 2006). 
Most importantly, vitrified spermatozoa were successfully utilized in ICSI treatment with 
clinical pregnancy resulting in delivery of healthy twins (E. Isachenko et al., 2011). While 
only a small volume 0.2 to 40 µl of sample suspension was frozen in the past, recently larger 
amounts of spermatozoa (100 µl) were successfully vitrified using newly developed straw 
packaging system  (SPS) made from cut in half 0.25 ml plastic straw (E. Isachenko et al., 
2011). A first live birth was reported following intrauterine insemination of semen vitrified 
without permeable cryoprotectants from patient with oligoasthenozoospermia making this 
freezing technique even more attractive in clinical practice (Sanchez al., 2011).  
3.2 Vitrification of human spermatozoa: Canadian experience 
Encouraged by the findings of the German group, we have also looked at possibilities to 
utilize vitrification in our laboratory. We have compared sperm motility, kinetics and DNA 
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damage between semen samples cryopreserved by standard vapour freezing verses 
vitrification protocols (Moskovtsev et al., 2011). Semen samples from 11 patients presenting 
for infertility were washed by density gradient centrifugation and evaluated by Computer-
Aided Sperm Analysis (CASA). Subsequently kinematic parameters were assessed as 
previously described: sperm motility, average path velocity (VAP) curvilinear velocity 
(VCL), straight-line velocity (VSL), linearity (LIN), amplitude of lateral head displacement 
(ALH) (Moskovtsev et al., 2009). However, kinematic parameters are averages of values 
obtained from analyzing the entire motile fraction of cells in a sample and include absolute 
(actual) parameters (VAP, VCL, VSL, ALH) and relative (derived) such as LIN. When 
cryopreserved samples are evaluated after thawing, the CASA-paradox can take place, 
when despite of deterioration of semen samples after cryopreservation “pseudo-
enhancement” of kinematics characteristics is observed (Katkov & Lulat, 2000). Modified 
Kinematic Parameters (MKP) were calculated as previously described: Kinematic 
Parameters (KP) x Motility/ 100% To account for this phenomenon, modifications of actual 
CASA-parameters are recommended and are incorporated into our data (Table 1). (Katkov& 
Lulat, 2000). 
 
Parameters 
Prior to 
freezing 
Post 
vitrif. 
Post 
vitrif. 
MKP 
Post slow 
freezing 
Post slow 
MKP 
P (vitrif. 
vs. slow 
freezing) 
Motility (%) 68.0 ± 10.79 25.4 ± 13.6  14.6 ± 10.2  < 0.05 
Rapid 
motility 
(% of motile) 
50.64 ± 4.52 19.45 ± 12.98 4.9 ± 3.3 10.45 ± 8.49 1.5 ± 1.2 < 0.05* 
VAP  
(microns/sec) 
60.73 ± 8.93 43.09 ± 14.24 10.9 ± 3.6 38. 00 ± 8.57 5.5 ± 1.2 < 0.05 
VSL 
(microns/sec) 
47.73 ± 9.39 35.45 ± 13.98 9.0 ± 3.5 31. 00 ± 8.27 4.5 ±1.2 < 0.05 
VCL 
(microns/sec) 
96.18 ± 3.68 81.18 ± 21.31 20.6 ± 5.4 68.73 ± 13.01 10.0 ± 1.9 < 0.05 
ALH 
(microns) 
4.42 ± 0.79 4.3182 ± 0.80 1.1 ± 0.2 3.67 ± 0.85 0.5 ± 0.1 < 0.05 
LIN 
(ratio of 
VSL/VCL) 
49.91 ± 0.55 42.45 ± 7.43 10.8 ± 1.9 45.91 ± 5.59 6.7 ± 0.8 < 0.05 
TUNEL (%) 7.5 ± 5.5 9.6 ± 4.4  9.5 ± 5.1  NS 
Note: * Statistically significant P values, when compared between MKP of samples frozen by 
vitrification vs. slow freezing. 
Table 1. Comparison of CASA and TUNEL resuls between semen samples frozen by 
vitrification and slow freezing. 
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Our results indicate that sperm motility was significantly reduced for both types of frozen-
thawed samples (P <0.03) (Table 1). Mean motility of vitrified samples was 25.4% ± 13.6 (a 
decrease of 36.4% compared to samples prior to freezing), which was almost two-fold higher 
compared to motility of samples frozen by standard slow vapour protocol (14.6% ± 10.2, 
decrease of 47.2% compared to samples prior to freezing), (P <0.05). Sperm kinematics such 
as VCL, VSL, and LIN were not significantly different between the two types of 
cryopreservation protocols without taking into account CASA- paradox. However, when 
MKP were calculated, it was revealed that indeed vitrified samples had superior recovery of 
sperm kinematic parameters in comparison to slow freezing. 
Samples for slow vapour freezing were diluted 3:1 with commercial cryoprotectant medium 
and frozen by standard protocol in CBS. Aliquots of samples for vitrification were diluted 
1:1 with a G-IVF medium (Vitrolife, Göteborg, Sweden) supplemented with 0.25M sucrose 
and 1% of LSPS (Life Global Protein Supplement, IVF Online, Guelph, ON, Canada). We 
have used 0.5 ml OPS and loaded 5 µl of vitrified sample in each straw by capillary; OPS 
were inserted into 0.5 CBS straws and sealed (Figure 1). 
      
Fig. 1. Comparison of 0.5 ml CBS straw and  0.5 cc OPS straw and schematic of OPS inserted 
and sealed inside a CBS. 
Samples were immediately plunged into LN2 and stored there for several days. For thawing 
procedure, OPS were rapidly removed from CBS straws, and plunged into 2 ml of the same 
medium used for vitrification at 37ºC for 10 seconds. 
We have evaluated the effect of cryopreservation on sperm DNA damage as the subject 
remains controversial. |While several reports indicate no negative effect of freezing on 
sperm DNA integrity (Duty et al., 2002; V. Isachenko et al., 2004). others have reported 
significant negative effect of sperm cryopreservation and DNA damage and chromatin 
stability (Hammadeh et al., 1999; Said et al., 2010). Significant increase in percentage of DNA 
fragmentation was associated with an increase in oxidative stress during cryopreservation 
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(Thomson et al., 2009). A slide-based technique for the assessment of sperm DNA was 
performed as previously described (TUNEL: TdT-mediated dUTP nick end labelling) 
(Moskovtsev et al., 2010) (Figure 2). 
 
Note: Brown (TUNEL-positive): damaged DNA; gray-green (TUNEL-negative): undamaged cells. 
Fig. 2. Sperm DNA damage assessment by TUNEL assay.  
We found statistically significant increase in sperm DNA damage after both methods of 
sperm freezing (P < 0.05). However, the increase in DNA damage was minimal and to a 
degree probably irrelevant to clinical concerns. No significant differences were observed in 
sperm DNA damage between slow freezing and vitrification (9.6 ± 4.4 vs. 9.5 ± 5.1).  
We can now confirm previous reports that human spermatozoa can be successfully vitrified 
without the use of potentially toxic cryoprotectants. The vitrification protocol showed 
significantly better results in preserving motility rates of spermatozoa when compared to 
slow vapour freezing. No significant differences were observed in post thaw sperm DNA 
damage in comparison to the standard slow freezing method. While our results are based on 
the freezing of a small volume of specimens, we are evaluating vitrification of larger 
volumes of spermatozoa with a proprietary mixture developed in our laboratory in CBS. We 
have achieved comparable results with both small volume (5 µl) and relatively large volume 
of 200 µl semen samples (unpublished data).  
4. Sperm banking 
4.1 Referring patients to a sperm bank  
Human semen cryobanking can be divided into two broad categories: autologous banking 
for personal fertility preservation and donor sperm banking. Semen banking is useful in 
many situations and can be considered a safeguard against unforeseen future circumstances. 
These may include: prior to chemotherapy or radiation therapy; pre- vasectomy; before 
certain types of pelvic or testicular surgery; in cases of degenerative illnesses such as 
diabetes or multiple sclerosis, spinal cord disease or injury; high risk occupations or sports; 
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and preparation for future fertility treatment. Usually several steps are required prior to 
initiation of semen storage. Most sperm banks only accept patients referred by their 
physician, however sometimes self referral is possible. Patients have to be screened by 
collection of blood, urine and semen samples to ensure that their samples will not 
contaminate others with infectious diseases when placed into storage. Consent for freezing 
and storage of semen has to be signed and witnessed. It is important that patients have a 
clear understanding of the process of banking and that they provide clear instructions on 
who is responsible for the disposition of the specimens in the event of their demise. 
Similarly, costs associated with banking and long term storage need to be clearly defined 
and assigned in case the patient becomes incapacitated. When samples are either used for 
procreation, transported to another facility, or storage is to be discontinued, the patient or 
designate must complete specific consent forms allowing the bank to comply with their 
wishes. In most countries it is assumed or stated by law that the semen belongs to the 
individual who produced the sample, and it is this individual who must sign all consents, 
unless the sample was designated for donation (e.g., in the case of anonymous sperm 
donation). If possible, multiple donations are usually recommended to ensure an adequate 
sperm reserve for future procreation, depending on the quality of the sample, individual 
circumstances and reason for sperm banking.  
4.2 Methods of sperm collection and retrieval  
In most cases patients are able to produce an ejaculate by masturbation. Patients are given 
instructions to have minimum of 2 days and a maximum of 5 days of sexual abstinence, and 
to collect an entire ejaculate into a sterile specimen container. Condoms, creams or 
lubricants must not be used during collection as they can interfere with sperm motility and 
vitality due to the spermicidal properties of many products. Some patients would not be 
able to produce sample at the sperm bank by masturbation due to psychological, medical 
reasons or religious restrictions. In this case collection of samples by intercourse using a 
non-spermicidal condom, often referred to as a “semen collection device”, is acceptable. 
Penile vibratory stimulation (PVS) can be helpful in spinal cord injury patients and those 
who are unable to produce semen by masturbation or intercourse (Brackett et al., 1998). 
However samples collected after PVS often exhibit relatively low motility (Hovav et al., 
2002). PVS can help to produce a semen sample in most patients with spinal cord injuries 
(Brackett et al., 1998). 
In some situations, collection of a retrograde sample is necessary. Retrograde ejaculation is a 
condition in which some or all of the sperm are not expelled through the urethra during 
ejaculation, but because of an incompetent bladder neck, the ejaculate refluxes back into the 
bladder. Reasons for this problem include organic conditions such as diabetes or multiple 
sclerosis, or pharmacological effects (eg. alpha adrenergic blocker use for hypertension). The 
general approach is to neutralize the urine pH and normalize the urine osmolarity by giving 
the patient sodium bicarbonate to alkalinize his urine. The urine sample is subsequently 
washed and used for insemination, in-vitro fertilization or cryopreservation. In patients 
with anejaculation, electro-ejaculation might be necessary to obtain semen, but this usually 
requires anaesthesia and has the associated risk of rectal injury. Additionally, samples 
produced by electro-ejaculation tend to be of relatively low quality (Denil et al., 1996).  
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Surgical sperm retrieval should be the last option in patients who can not produce a sample 
or patients who are diagnosed with azoospermia. Several methods of sperm retrieval are 
available depending on the etiology of the problem. To retrieve epididymal spermatozoa in 
cases of obstruction, percutaneous epididymal sperm aspiration (PESA) can be performed 
without surgical scrotal exploration, it is repeated easily, and does not require an operating 
microscope or expertise in microsurgery. Microsurgical epididymal sperm aspiration 
(MESA) is performed under the operating microscope and general anaesthesia. Individual 
tubules of the epydidymis are isolated and aspirated. Testicular sperm aspiration (TESA) is 
a needle biopsy of the testicle. It is an office procedure performed under local anaesthesia. 
Testicular sperm extraction (TESE) is the process of making a small incision and removing a 
small portion of tissue from the testicle under sedation or local anaesthesia. Microdissection 
(or sometimes referred to as microscopic or microsurgical) testicular sperm extraction 
(MicroTESE) is a very rigorous search for sperm under high magnification in cases of 
azoospermia or extremely low sperm production. MicroTESE is usually performed in the 
operating room under general anaesthesia utilizing an operating microscope. 
Cryopreservation of surgically retrieved epididymal and testicular spermatozoa is a 
valuable component in the effective treatment and management of these patients and it 
reduces the necessity of repeat surgeries when the intial procedure is unsuccessful or if 
additional children are desired.  
4.3 Long term storage  
Proper long term storage is usually achieved by placing specimens in LN2 freezers, which 
have been safely used since the 1970s. Some automated systems are available and are 
capable of LN2 autofilling, supplied with alarms and data recordings for all activities and 
are designed to minimize the chances of loss or damage of samples. Despite automation, 
quality control procedures must be implemented by sperm banks to ensure proper 
monitoring and safety of samples and staff. The LN2 itself can be a source of microbial 
contamination so every available practical step has to be considered to reduce the risk of 
transmission (Fountain et al., 1997). In general cross-contamination of frozen samples by 
pathogens are extremely rare, and have not been reported in the setting of sperm banks. It 
is, however, theoretically possible, as often patients are not fully screened prior to freezing, 
as in cases of autologous sample cryopreservation or due to time constraints for oncology 
banking (Clarke, 1999). “Quarantine'” tanks are often used to separate samples with 
pending, unclear laboratory results or unscreened patients. However, contamination is still 
possible, as released samples that are moved to long term storage could have acquired 
pathogenic contamination from one of other “pending” samples in the quarantine tank. 
When samples are cryopreserved for patients with known infections such as HIV or 
hepatitis B and C carriers, separate tanks for each type of infection are required (Tomlinson 
& Sakkas, 2000). Cross-contamination can also be avoided by storage of samples in nitrogen 
vapour. However, in contrast to liquid nitrogen, there are some concerns that vapour has 
poor heat transfer rates, lower thermal capacity, and significant temperature fluctuation 
may exist within the vapour(Tomlinson & Saakas, 2000; Wood, 1999). Some older types of 
vapour storage systems could only guarantee the maintenance of temperature around -
100°C and were not acceptable for long term sperm storage. Storage temperatures have to be 
maintained below -135°C to ensure a glass-like condition of frozen water and for secure long 
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term storage of semen samples (Clarke, 1999). Newer types of high efficiency LN2 vapour 
freezers and others that have a LN2 “jacket”' provide working environments of below -
160°C and are more suitable for sperm banks.  
4.4 Quality control and quality assurance 
Amongst the many government or professional organizations that require periodic 
inspection of frozen samples, the standards put forward by Health Canada are the strictest 
(Health Canada, 2000). Rigorous standards of operation are essential for sperm banks. 
Sperm banks must have specific requirements for screening, processing and quarantine of 
samples. Licensing is required in some countries and sperm banks are inspected in 
accordance with existing standards or regulations. While auditing is absolutely necessary, it 
might pose the risk of exposure of frozen specimens to room temperature while such 
inventory is performed. Straws thaw more rapidly than vials and can warm up to -80°C 
within 8 to 15 seconds at room temperature, dramatically increasing the possibility of 
damaging samples during inventory or verification of samples’ identity (Tyler et al., 1996). 
Clear labelling systems to easily identify and link samples to a specific donor or patient 
must be in place to enable sample location and for performing inventory. The samples 
should remain in LN2 during the duration of inventory performance and the audit must be 
performed by qualified and skilled staff.  
Several facility and equipment-related quality control and risks factors must be considered 
for cryopreservation and storage of semen. Physical security of bank facilities and proper 
identification of sample location within freezers is crucial. Equipment must be appropriate 
and functional, with defined periodic service and maintenance schedules. Staff must be 
supplied with all necessary personal protective equipment. Adequate supplies of LN2 gas 
must be guaranteed and spare LN2 prefilled tank must be available in case of emergency. 
All staff involved in handling LN2 must be properly trained by a certified organization. 
Standard operating procedures must be developed to clearly describe each step of the 
process of sample collection, processing, banking and handling. Annual reviews of both 
proper documentation and LN2 training must be performed. Temperature of freezers 
chambers and LN2 levels in tanks must be monitored on a continuous basis and all data 
logged in secure databases. Alarm systems and appropriate call procedures must be in place 
to attend to any emergencies. 24 hour monitoring and response is absolutely essential to 
safely maintain the integrity of the clinical samples in storage. Storage rooms must be 
monitored continuously for O2 levels and staff activity in enclosed spaces must be 
monitored to avoid hypoxic injury. Backup power generation must be available in the event 
of a power failure. Each sample designated for storage has to be properly verified, assessed, 
processed, labelled, frozen and stored. Double-checking the identity of samples at each step 
is highly recommended. Some banks choose to divide samples from individual patients or 
couples and store them in different tanks or locations to minimize the risk of total loss of 
their biologic material (WHO, 2010).  
5. Sperm donation 
5.1 Applications for sperm donation 
In cases of severe male infertility, single or lesbian women, the use of donor sperm is the 
only approach to address fertility issues (Botchan et al., 2001; Golombok, 2005). Advances in 
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sperm cryopreservation have created opportunities for many families to achieve 
pregnancies through therapeutic donor insemination or IVF with donor sperm. Pregnancy 
rates are estimated to be around 10-12% per unstimulated cycle and can be achieved when 
at least 5 × 106 progressively motile spermatozoa inseminated into the lower cervical canal 
on 2–3 occasions during the ovulatory phase of menstrual cycle (Scott et al., 1990). At 
present, some 30,000 births per year worldwide are attributable to frozen donor sperm 
inseminations (Mortimer, 2004). While this seems like a large number, it may fall in the 
future, as the recruitment of sperm donors is increasingly difficult due to complicated and 
strict regulatory procedures, as well as lack of interest from potential donors. 
The screening process for donor sperm is quite rigorous and includes obtaining a complete 
medical and sexual history, physical examination, psychological assessment and laboratory 
work-up on blood, urine and semen specimens to screen for pathogens including Hepatitis 
B, C, Human Immunodeficiency Virus (HIV 1&2), Human T-cell Lymphotrophic Virus 
(HTLV 1&2), Treponema pallidum (Syphilis), Cytomegalovirus, Chlamydia trachomatis and 
Neisseria gonorrhoea. Sperm banks perform genetic screening for heritable diseases based 
on the ethnic background of sperm donors (eg. Cystic Fibrosis for Caucasians). Donors must 
be retested after the required quarantine interval, and specimens may be released only if the 
results of repeat testing are negative. Specimens can only be used after they have been 
quarantined for a minimum of 180 days to avoid the risk of HIV transmission. Donor 
eligibility restrictions apply to employees of sperm banks, poor donors’ health or quality of 
the semen and in some countries by sexual orientation of the donor, as gay or bisexual men 
are considered at higher risk for HIV and prohibited from being sperm donors in some 
countries (including Canada and USA). Many countries have age restrictions for sperm 
donation. The minimum age is usually 18 and the maximum 40 years of age (Health Canada 
2000, American Society for Reproductive Medicine (ASRM), 2004)   
5.2 Anonymous donors  
Semen donors can be classified into two specific groups, anonymous and non-anonymous 
(known). Currently, with the establishment of many commercial sperm banks and the 
ability to safely transport samples even between continents, anonymous sperm donation is 
the method of choice for most recipients. The anonymity of the donor is maintained through 
the process. This is an important issue to both the recipient and the donor (Ernst et al., 2007). 
For fully anonymous sperm donation, the recipients would not be known to the donor and 
the donor offspring would have no future contact with the donor. The sperm donor gives up 
all legal rights over the biological children conceived from his samples donated to sperm 
bank. Anonymous donation allows parents, if they wish, to conceal the issue of infertility, or 
the fact of non-genetic parenting from the offspring. The motivation to hide this information 
most commonly is driven by pressure from other family members; fear of being rejected by 
the child or to protect children from the complicated psychosocial matters related to sperm 
donation. In many Western countries disclosure is encouraged by many counsellors, and if 
open disclosure is chosen by the parents, it is usually advised to disclose the method of 
conception to their children at an early age. Non-disclosure by parents of the biological 
origin of their children is viewed by some as misleading the child and could potentially 
affect trust between parents and their children, if their origin eventually becomes known to 
the child (Patrizio et al., 2001). However, it is ultimately the decision of the parents to 
disclose or not as in adoption cases. 
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There is some consensus that there should be limits on the number of offspring allowed 
from a given sperm donor. This is driven by possibility of accidental consanguinity between 
children from the same sperm donor. For example ASRM recommends a limit of 25 children 
per population of 800 000 for a single donor,  but there are no federal or state laws limiting 
the number of sperm donation by a donor. In UK the number is limited to 10 different 
families, but does not apply if a genetically related sibling for an existing child is desired. 
Some countries limit the number of children to 4 in New Zealand; 5 in China; and 5 to 10 in 
Australia depending on the region; 25 in the Netherlands (Gong et al., 2009).  
Recently, open-identity sperm donors have become available through many sperm banks. 
These donors have agreed to at least a single contact with any children born through use of 
their sperm, usually when the child reaches the age of consent (18 years old in most 
jurisdictions), for those individuals who wish to contact them (Gottlieb et al., 2000; Frith et 
al., 2007). In some cases audio interviews and pictures are available from these donors. 
Two types of anonymous donor samples are usually available through sperm banks, 
prewashed or unwashed: Prewashed samples are obtained by processing the ejaculate by 
density gradient centrifugation for seminal fluid removal prior to freezing and can be 
directly inseminated into the uterine cavity after thawing (Larson et al. 1997). These samples 
are favoured by doctors’ offices without access to an Andrology laboratory for post thaw 
processing. For processing unwashed samples, density gradient isolation is required to 
remove contaminants and CPAs after thawing the specimen prior to intrauterine 
insemination or for IVF. The removal of CPAs has to be performed step-by-step and 
gradually to minimize osmotic stress on spermatozoa. Drop-wise dilution of the sample 
with 1:10 sample to sperm wash medium ratio is recommended (Mortimer, 2004).  
5.3 Non-anonymous sperm donors 
Some donors and recipients choose to arrange donations privately and the donor in this case 
is known to the recipient(s). The donor may be a family member such as a brother or father 
or a friend. Most of these donations are done altruistically and acceptable only if all parties 
are in agreement. All participants involved in the donation process are generally required to 
attend a separate and a joint counselling session. An initial counselling interview with the 
donor and his spouse or partner (if applicable) is arranged to discuss the personal, social 
and legal aspects of donation. The known donor has to meet all requirements to be accepted 
for donation and undergo the same screening tests and laboratory evaluation as an 
anonymous donor, including 180 days quarantine for his frozen sample. Proper consent and 
declaration forms are required to be signed by known semen donor. Furthermore, a child 
conceived using donated semen is legally deemed to be the child of the recipient(s), and the 
donor has no legal rights or responsibilities regarding the child. Usually the donor may at 
any time prior to the use of his semen, vary or revoke his consents. Most clinics require a 
legal contract with all parties having received independent legal advice.  As the use of the 
third party reproduction such as sperm and egg donation becomes more acceptable in many 
countries the ethical and legal aspects of these procedures become increasingly important. 
Issues of the donor’s anonymity, financial compensation, religion and cultural acceptance, 
regulation of donor and prospective parent screening, as well as consideration of the welfare 
of children conceived with the use of donor sperm are widely discussed in the scientific 
literature and public media. While guidelines on the use of donated sperm come from 
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government or professional organizations, they may also be influenced by religious 
institutions and they vary widely from country to country (Gong, 2009).  
6. Social importance and psychological aspects around banking oncology 
patients, adolescent and young adults 
When an individual is diagnosed with cancer almost every aspect of their physical and 
psychosocial well-being is altered. Quite often in clinical practice, the long term effects of 
cancer therapy on a patients’ ability to have children in the future is not adequately 
addressed (Thaler-DeMers, et al., 2001). While the priority is to eliminate the cancer and 
save their life, fertility preservation especially among adolescent or young adults to ensure 
the potential of procreation with their own gametes after treatment, needs to be considered. 
Impaired spermatogenesis has been demonstrated before treatment in some patients with 
malignancies, depending on their location (eg. testicular cancer) or type (eg.Hodgkin’s 
lymphoma) (Rueffer et al., 2001). Current treatment options such as surgery, chemotherapy 
and/or radiation can impair spermatogenesis and sexual function and lead to temporary or 
permanent infertility (Magelssen et al., 2006).  
The scale of negative effects of cancer treatment on spermatogenesis depend on the specific 
gonadotoxicity of administered chemotherapeutic agents, number of chemotherapy 
treatment cycles, radiotherapy field location and dosage, type and stage of the cancer, and 
age of the patient. Considering combination cancer therapy, uncertainty in individual 
response to treatment and the large number of confounding variables, it becomes very 
challenging to assess the risk of iatrogenic infertility in many patients. The ability of cancer 
survivors to have their own biological offspring is very important for many oncology 
patients, especially at younger ages (Schover et al., 1999). Advances in early diagnostic 
investigation and treatments have led to increasing numbers of young cancer survivors. 
Unfortunately up to 30% of childhood cancer survivors are permanently sterile following 
cancer treatment (Tournaye et al., 2004). In Canada and the United States, cancer in patients 
15 to 29 years of age who can benefit from sperm banking is nearly three times more 
common than in patients younger than 14 years (Bleyer et al., 2006). Early germ cells, 
(spermatogonia) are very sensitive to radiation and chemotherapy. Even low doses or a 
single dose treatment can potentially cause functional impairment of spermatogenesis. With 
increase in dosage or duration of the treatment, initially spermatocytes get damaged and as 
treatment progresses spermatids also become damaged. Radiation doses of less than 0.8 Gy 
can result in oligospermia and doses between 0.8 and 3 Gy can result in azoospermia 
(Rivkees & Crawford, 1988).  
Cryopreservation of semen has changed the reproductive prospects for young patients 
diagnosed with cancer. Unfortunately, banking services continue to be underutilized since 
cancer patients and their families are not always informed about the potential fertility risks 
associated with cancer treatments, or the availability of banking. According to some 
surveys, less than 20% of patients undergoing chemotherapy or radiation treatment are 
informed about the adverse effects of such treatment on spermatogenesis or are offered 
sperm banking for fertility preservation. Cancer patients are usually under huge 
physiological and time pressure to make cryopreservation decisions while dealing with a 
life threatening situation. To complicate matters, some young patients are unable to produce 
semen samples by masturbation. In such cases, PVS or electro-ejaculation under general 
anaesthetic might be required. Surgical retrieval of testicular tissue may be an option for 
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prepubertal boys who are not capable of producing mature sperm. Testicular tissue 
cryopreservation has been reported in boys with cryptorchidism to preserve fertility 
(Bahadur et al., 2000). Cryopreserved testicular tissues can be autografted to restore 
reproductive functions; however recurrence of neoplastic process is a concern in oncology 
patients and such procedures are still considered to be experimental (Hwang & Lamb, 2010). 
A multi-disciplinary team approach is important to ensure that patients have the 
opportunity to preserve their fertility potential if they elect to do so. 
The posthumous use of semen is an entirely separate and complex ethico-legal subject. The 
ethical and legal aspects of posthumous assisted reproduction have been recently addressed 
by the European Society of Human Reproduction and Embryology Task Force on Ethics and 
Law (ESHRE, 2006). 
7. Conclusions 
Human spermatozoa can be successfully cryopreserved and utilized. Cryopreservation now 
plays an essential role in fertility preservation under the following scenarios: 
 couples undergoing infertility treatment.  
 cancer patients undergoing gonadotoxic chemotherapy or radiation. 
 patients undergoing certain types of pelvic or testicular surgeries 
 patients suffering from degenerative illnesses such as diabetes or multiple sclerosis; 
spinal cord disease or injury. 
 men undergoing surgical sterilization such as vasectomy 
 screening and quarantine of donor semen samples 
Normozoospermic semen samples appear to be more tolerant to damage induced by 
freezing and thawing compared with oligozoospermic or asthenozoospermic samples. 
Cryopreservation of surgically retrieved epididymal and testicular spermatozoa is 
challenging, but a valuable component in effective treatment and management of severe 
male factor infertility. Cryopreservation of low numbers or single spermatozoa has multiple 
biological and technical aspects yet to be worked out; therefore, further research is required 
to introduce this technique into clinical practice. During cryopreservation, cells and tissue 
undergo dramatic transformation in chemical and physical characteristics as temperature 
drops from +37 to -196°C, thus risking cryoinjury. Velocity of cooling and warming is 
crucial and inaccurate cooling or thawing rates negatively correlate with sperm survival. 
Spermatozoa cannot survive slow freezing without CPAs; CPAs have to be used at low 
concentrations with minimum exposure as CPAs are toxic and can cause osmotic damage. 
Gradual, stepwise introduction before freezing and removal of CPAs after thawing is 
essential. Conventional slow freezing with CPAs can offer cooling rates of 1–10°C/min. 
Vitrification, currently only an experimental technique, allows for extremely rapid freezing 
at rates of up to a 1000°C/min. LN2 can offer long-term survival of spermatozoa due to 
essentially absent metabolic activity and aging of cells and tissues in the frozen state. 
Rigorous standards of operation and quality control are essential for sperm banks. Social, 
psychological, legal and ethical issues surrounding sperm banking are very complex and 
must be considered in each case.  
The vitrification method uses no specially developed cooling program; it does not need 
permeable cryoprotectants; it is much faster, simpler and cheaper; and it can also provide a 
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high recovery of motile spermatozoa after warming as effective protection of spermatozoa 
against cryodamage and helps to avoid many problems relevant to slow freezing such as ice 
formation; shifts in pH, extensive rehydration and osmotic damage.  
Successful vitrification of human spermatozoa without toxic CPAs has been reported now 
by two independent groups. Moreover, live births were reported after vitrification of semen 
utilized for intrauterine insemination and IVF with ICSI procedures, making this freezing 
technique even more attractive in clinical practice.  
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